glaucoma laser surgery headline image
 

horizontal bar

Glaucoma Treatments Links


Couldn't open rss feed in /links/glaucoma_treatments_page_1.php
Couldn't open rss feed in /links/glaucoma_treatments_page_1.php
<< 1 2 3 >>



Warning: fopen(includes/rss-cache/amazon-Books-glaucoma) [function.fopen]: failed to open stream: No such file or directory in /home/binaura/public_html/SLTSecrets.com/includes/amazon.php on line 984

Warning: fwrite(): supplied argument is not a valid stream resource in /home/binaura/public_html/SLTSecrets.com/includes/amazon.php on line 985

Warning: fclose(): supplied argument is not a valid stream resource in /home/binaura/public_html/SLTSecrets.com/includes/amazon.php on line 986

Warning: Invalid argument supplied for foreach() in /home/binaura/public_html/SLTSecrets.com/includes/amazon.php on line 1053

 

SLT Secrets Recommended Products


Glaucoma Treatments Headlines

Glaucoma, often unsuspected, leads to blindness without treatment - New York Daily News


New York Daily News

Glaucoma, often unsuspected, leads to blindness without treatment
New York Daily News
Her patients have glaucoma. “Glaucoma is a disease that causes loss of vision and eventually blindness if not adequately treated,” says Serle. “This is a disease that we can manage with medication, laser treatments and surgery — but far too many ...

Read more...


Macular Degeneration AMD Treatment Advances Mark Awareness in Maine - EIN News (press release)


Macular Degeneration AMD Treatment Advances Mark Awareness in Maine
EIN News (press release)
The key to successful treatment is early detection and intervention. Eyecare Medical Group is a leading ophthalmology practice in Portland, Maine staffed by a team of eye care specialists including eye doctors who are fellowship trained glaucoma ...

and more »

Read more...


pSivida CEO to Participate in Panel at Glaucoma 360 Conference February 3 - MarketWatch (press release)


Proactive Investors Australia

pSivida CEO to Participate in Panel at Glaucoma 360 Conference February 3
MarketWatch (press release)
pSivida is currently focused on the treatment of chronic diseases of the back of the eye utilizing its core technology systems, Durasert(TM) and BioSilicon(TM). Its present programs include infectious uveitis, glaucoma and Tethadur(TM).
pSivida Corp. : pSivida CEO to Participate in Panel at Glaucoma 360 Conference ...4-traders (press release)

all 15 news articles »

Read more...


ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of ... - MarketWatch (press release)


ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of ...
MarketWatch (press release)
ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in ...

and more »

Read more...


Local Eye Care Specialists explain risks and treatment options for glaucoma - Sussex Sun


Local Eye Care Specialists explain risks and treatment options for glaucoma
Sussex Sun
Loss of side vision is a common sign of glaucoma. Gonioscopy: A special hand-held contact lens with a mirror inside is used to examine the angle where the iris meets the cornea. This helps determine the type of glaucoma and treatment plan.
NIH statement on Glaucoma Awareness Month, January 2012PressZoom (press release)
Ophthalmology group offers free glaucoma screening and eye examsSTLtoday.com

all 7 news articles »

Read more...


 
Home · Sitemap